AU5659990A - Method of treatment of hepatitis - Google Patents

Method of treatment of hepatitis

Info

Publication number
AU5659990A
AU5659990A AU56599/90A AU5659990A AU5659990A AU 5659990 A AU5659990 A AU 5659990A AU 56599/90 A AU56599/90 A AU 56599/90A AU 5659990 A AU5659990 A AU 5659990A AU 5659990 A AU5659990 A AU 5659990A
Authority
AU
Australia
Prior art keywords
dideoxycytidine
administered
ddc
hepatitis
dna
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU56599/90A
Other languages
English (en)
Inventor
Samuel Broder
Jay H. Hoofnagle
Hiroaki Mitsuya
Robert Yarchoan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
US Department of Commerce
Original Assignee
US Government
US Department of Commerce
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by US Government, US Department of Commerce filed Critical US Government
Publication of AU5659990A publication Critical patent/AU5659990A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Application Of Or Painting With Fluid Materials (AREA)
AU56599/90A 1989-05-15 1990-05-15 Method of treatment of hepatitis Abandoned AU5659990A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US35151989A 1989-05-15 1989-05-15
US351519 1989-05-15

Publications (1)

Publication Number Publication Date
AU5659990A true AU5659990A (en) 1990-12-18

Family

ID=23381258

Family Applications (1)

Application Number Title Priority Date Filing Date
AU56599/90A Abandoned AU5659990A (en) 1989-05-15 1990-05-15 Method of treatment of hepatitis

Country Status (5)

Country Link
EP (1) EP0472595A4 (ja)
JP (1) JPH04501854A (ja)
AU (1) AU5659990A (ja)
CA (1) CA2055433A1 (ja)
WO (1) WO1990014079A1 (ja)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5039667A (en) * 1987-08-07 1991-08-13 The Governors Of The University Of Alberta Antiviral therapy for hepatitis B with 2',3'-dideoxypurine nucleosides
IL100502A (en) * 1991-01-03 1995-12-08 Iaf Biochem Int PHARMACEUTICAL PREPARATIONS CONTAINING CIS-4-AMINO-1-) 2-HYDROXIMETHIL-1,3-OXETYOLEN-5-IL (-
US6812233B1 (en) 1991-03-06 2004-11-02 Emory University Therapeutic nucleosides
GB9104740D0 (en) * 1991-03-06 1991-04-17 Wellcome Found Antiviral nucleoside combination
DE4110977A1 (de) * 1991-04-05 1992-10-08 Bayer Ag Substituierte 2',3'-didesoxy-5-trifluormethyluridine, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
GB9109506D0 (en) * 1991-05-02 1991-06-26 Wellcome Found Therapeutic nucleosides
GB9110874D0 (en) * 1991-05-20 1991-07-10 Iaf Biochem Int Medicaments
GB9226927D0 (en) * 1992-12-24 1993-02-17 Iaf Biochem Int Dideoxy nucleoside analogues

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3817982A (en) * 1971-12-29 1974-06-18 Syntex Inc 2{40 ,3{40 -unsaturated nucleosides and method of making
US4666892A (en) * 1984-03-06 1987-05-19 Sloan-Kettering Memorial Cancer Center Method and composition for hepatitis treatment with pyrimidine nucleoside compounds
US4719235A (en) * 1984-10-16 1988-01-12 Gerald N. Kern Methods and compositions for treating viral infection
NZ216172A (en) * 1985-05-15 1989-08-29 Wellcome Found Nucleosides and pharmaceutical compositions
WO1987001283A1 (en) * 1985-08-26 1987-03-12 United States Of America, Represented By The Unite Inhibition of in vitro infectivity and cytopathic effect of htlv-iii/lav by 2',3'-dideoxycytidine
CA1327000C (en) * 1987-08-07 1994-02-15 David L.J. Tyrrell Antiviral therapy for hepatitis b
JP2648329B2 (ja) * 1987-09-18 1997-08-27 エフ・ホフマン−ラ ロシュ アーゲー エイズの予防または治療用医薬組成物

Also Published As

Publication number Publication date
EP0472595A1 (en) 1992-03-04
WO1990014079A1 (en) 1990-11-29
JPH04501854A (ja) 1992-04-02
CA2055433A1 (en) 1990-11-16
EP0472595A4 (en) 1992-07-08

Similar Documents

Publication Publication Date Title
KR100854398B1 (ko) 베타-ｌ-2'-데옥시-뉴클레오사이드를 이용한 델타형 간염바이러스 감염의 치료방법
US5246924A (en) Method for treating hepatitis B virus infections using 1-(2'-deoxy-2'-fluoro-beta-D-arabinofuranosyl)-5-ethyluracil
CN100528173C (zh) 4′-取代的核苷
CN1195526C (zh) 含对映体纯β－D－二氧戊环核苷的药物产品
FI85978B (fi) Foerfarande foer framstaellning av ett terapeutiskt anvaendbart salt eller ester av 3'-azido-3'deoxitymidin.
RU2139884C1 (ru) Моноэфирные соединения, фармацевтическая композиция
Kassianides et al. Inhibition of duck hepatitis B virus replication by 2′, 3′-dideoxycytidine: A potent inhibitor of reverse transcriptase
US20040023921A1 (en) Antiviral phosphonate compounds and methods therefor
JPH07116042B2 (ja) ヌクレオシド化合物
Heidelberger et al. Trifluorothymidine
CN1972696A (zh) 用于治疗rna依赖性rna病毒感染的核苷氨基磷酸芳基酯
EP1284720B1 (en) L-fmau for the treatment of hepatitis delta viral infection
US5039667A (en) Antiviral therapy for hepatitis B with 2',3'-dideoxypurine nucleosides
AU5659990A (en) Method of treatment of hepatitis
KR940010441B1 (ko) B형감염의 항비루스제
US5565437A (en) 2',3'-dideoxy-2'-fluoro-purine nucleosides and methods for using same
AU5832990A (en) Method of treatment of hepatitis
KR970011386B1 (ko) 1-(2'-데옥시-2'-플루오로-베타-d-아리비노-푸라노실)-5-에틸우라실을 이용한 간염 비루스 감염질환의 치료방법 및 치료용 조성물
WO1993013778A1 (en) Therapeutic nucleosides
Lofgren et al. 2 ‘, 3’‐dideoxy‐3 ‘‐fluoroguanosine inhibits duck hepatitis B virus in vivo
WO2024114709A1 (en) A crystal form of a fused heterocycle derivative compound
CA2075490A1 (en) 6-halo-and 2-amino-6-halo-purine 2',3'-dideoxy nucleosides and their use as antiviral agents